Details
Stereochemistry | RACEMIC |
Molecular Formula | C28H41N3O3.ClH |
Molecular Weight | 504.104 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCN(CCC)C(=O)C(CC1=CC=C(OCCN(CC)CC)C=C1)NC(=O)C2=CC=CC=C2
InChI
InChIKey=SVCQSEFEZWMYSA-UHFFFAOYSA-N
InChI=1S/C28H41N3O3.ClH/c1-5-18-31(19-6-2)28(33)26(29-27(32)24-12-10-9-11-13-24)22-23-14-16-25(17-15-23)34-21-20-30(7-3)8-4;/h9-17,26H,5-8,18-22H2,1-4H3,(H,29,32);1H
Tiropramide is an antispasmodic medication. It acts by increasing cAMP concentration in smooth muscle possibly because of inhibition of cAMP catabolism. The drug is marketed worldwide for the treatment of irritable bowel syndrome, biliary dyskinesia, acute spasmodic dysphoric syndromes, and other urological and gynecological disorders.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006939 |
19.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ALFOSPAS Approved UsePainful-spastic syndromes such as acute hepatobiliary colic, abdominal different nature, kidney or ureteral. Spasms and abdominal pain originating from gastrointestinal dyskinesia, cholelithiasis, cholecystitis, post-surgical adhesions. |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9523013Y6R
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
57227-16-4
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
DTXSID70972684
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
236681
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | RxNorm | ||
|
134448
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
53567-47-8
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
SUB15577MIG
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
m10892
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
260-634-0
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY | |||
|
100000091756
Created by
admin on Fri Dec 15 19:01:04 GMT 2023 , Edited by admin on Fri Dec 15 19:01:04 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD